DoW Tuberous Sclerosis Complex, Clinical Translational Research Award

Name: DoW Tuberous Sclerosis Complex, Clinical Translational Research Award
Creator: Department of Defense
Keywords: GRANT

Department of DefenseDefense Health Agency Contracting Activity - DHACA

AI Overview

This DoD award supports clinical translational research to advance tuberous sclerosis complex diagnosis, prognosis, and treatments from promising preclinical findings toward real-world clinical application. Multi-PI teams can collaborate on moving TSC research closer to patient care.

This summary is AI-generated from the official solicitation.

Key Details

Agency

Department of Defense

Funding Amount

Up to $3,500,000

Release Date

May 5, 2026

Due Date

August 6, 2026 (Closed)

Official Description

Summary: The fiscal year 2026 (FY26) Tuberous Sclerosis Complex Research Program (TSCRP) Clinical Translational Research Award (CTRA) supports studies that will move promising, well-founded preclinical and/or clinical research findings closer to clinical application, including diagnosis, prognosis or treatment of tuberous sclerosis complex (TSC). Distinctive Features: This funding mechanism allows for multiple Principal Investigat...

View on official source

Change History

Date ChangedJul 29, 2026 at 9:06 PM